VeriTeQ Awarded New U.S. Patent for Wireless Molecular Sensor System and Process

May 26, 2015 — VeriTeQ Corp. announced that it has been awarded a U.S. Patent for Wireless Molecular Sensor System and Process. The company intends to utilize the patent in the development of future bio-sensing microchip applications, initially focused on its radiation dose measurement technologies used during cancer treatment.

This newest patent covers methods and systems for measuring and wirelessly communicating particular molecular levels using an implantable sensor device operable without the use of batteries. These implantable biosensor systems use radio frequency technology to wirelessly transmit information between a transponder passively powered on a chip and a remote transponder. Information transmitted via this wireless communication system quantifies a physiological metric with respect to the levels of specific molecules measured by the biosensor.

The company plans to apply this patent in conjunction with its future radiation dose measurement products, to be used during cancer treatment therapies. Within its broad intellectual property portfolio, the company has an existing patent for implantable sensors that dynamically monitor multiple biological and physiological parameters, such as temperature to monitor hyperthermia.

For more information: www.veriteqcorp.com